Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

APYX vs SSKN vs ARAY vs ISRG vs LNTH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
APYX
Apyx Medical Corporation

Medical - Devices

HealthcareNASDAQ • US
Market Cap$149M
5Y Perf.-19.8%
SSKN
STRATA Skin Sciences, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$7M
5Y Perf.-98.6%
ARAY
Accuray Incorporated

Medical - Devices

HealthcareNASDAQ • US
Market Cap$35M
5Y Perf.-86.0%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$5.92B
5Y Perf.+562.8%

APYX vs SSKN vs ARAY vs ISRG vs LNTH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
APYX logoAPYX
SSKN logoSSKN
ARAY logoARAY
ISRG logoISRG
LNTH logoLNTH
IndustryMedical - DevicesMedical - DevicesMedical - DevicesMedical - Instruments & SuppliesDrug Manufacturers - Specialty & Generic
Market Cap$149M$7M$35M$161.07B$5.92B
Revenue (TTM)$56M$31M$429M$10.58B$1.55B
Net Income (TTM)$-9M$-11M$-46M$2.98B$279M
Gross Margin38.1%57.8%26.8%66.3%60.5%
Operating Margin-7.7%-33.3%-5.1%30.5%18.8%
Forward P/E43.8x17.5x
Total Debt$39M$16M$176M$303M$738K
Cash & Equiv.$32M$7M$57M$3.37B$359M

APYX vs SSKN vs ARAY vs ISRG vs LNTHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

APYX
SSKN
ARAY
ISRG
LNTH
StockMay 20May 26Return
Apyx Medical Corpor… (APYX)10080.2-19.8%
STRATA Skin Science… (SSKN)1001.4-98.6%
Accuray Incorporated (ARAY)10014.0-86.0%
Intuitive Surgical,… (ISRG)100234.6+134.6%
Lantheus Holdings, … (LNTH)100662.8+562.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: APYX vs SSKN vs ARAY vs ISRG vs LNTH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ISRG leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and profitability and margin quality. Lantheus Holdings, Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. APYX also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
APYX
Apyx Medical Corporation
The Momentum Pick

APYX ranks third and is worth considering specifically for momentum.

  • +184.8% vs SSKN's -93.3%
Best for: momentum
SSKN
STRATA Skin Sciences, Inc.
The Lower-Volatility Pick

SSKN lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
ARAY
Accuray Incorporated
The Healthcare Pick

Among these 5 stocks, ARAY doesn't own a clear edge in any measured category.

Best for: healthcare exposure
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 20.5% revenue growth vs LNTH's 0.5%
  • 28.2% margin vs SSKN's -35.6%
  • 14.8% ROA vs SSKN's -35.9%, ROIC 15.0% vs -38.9%
Best for: growth exposure
LNTH
Lantheus Holdings, Inc.
The Income Pick

LNTH is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.

  • Dividend streak 0 yrs, beta 0.47
  • 41.9% 10Y total return vs ISRG's 5.5%
  • Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
  • Beta 0.47, current ratio 2.70x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs LNTH's 0.5%
ValueLNTH logoLNTHLower P/E (17.5x vs 43.8x)
Quality / MarginsISRG logoISRG28.2% margin vs SSKN's -35.6%
Stability / SafetyLNTH logoLNTHBeta 0.47 vs ARAY's 2.42, lower leverage
DividendsTieNone of these 5 stocks pay a meaningful dividend
Momentum (1Y)APYX logoAPYX+184.8% vs SSKN's -93.3%
Efficiency (ROA)ISRG logoISRG14.8% ROA vs SSKN's -35.9%, ROIC 15.0% vs -38.9%

APYX vs SSKN vs ARAY vs ISRG vs LNTH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

APYXApyx Medical Corporation
FY 2025
OEM
100.0%$8M
SSKNSTRATA Skin Sciences, Inc.
FY 2024
Dermatology Recurring Procedures
63.1%$21M
Dermatology Procedures Equipment
36.9%$12M
ARAYAccuray Incorporated
FY 2025
Product
51.8%$238M
Service
48.2%$221M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M

APYX vs SSKN vs ARAY vs ISRG vs LNTH — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLNTHLAGGINGSSKN

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

ISRG is the larger business by revenue, generating $10.6B annually — 341.6x SSKN's $31M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SSKN's -35.6%. On growth, APYX holds the edge at +31.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricAPYX logoAPYXApyx Medical Corp…SSKN logoSSKNSTRATA Skin Scien…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…LNTH logoLNTHLantheus Holdings…
RevenueTrailing 12 months$56M$31M$429M$10.6B$1.5B
EBITDAEarnings before interest/tax-$4M-$5M-$15M$3.8B$347M
Net IncomeAfter-tax profit-$9M-$11M-$46M$3.0B$279M
Free Cash FlowCash after capex-$9M-$4M-$28M$2.8B$372M
Gross MarginGross profit ÷ Revenue+38.1%+57.8%+26.8%+66.3%+60.5%
Operating MarginEBIT ÷ Revenue-7.7%-33.3%-5.1%+30.5%+18.8%
Net MarginNet income ÷ Revenue-16.4%-35.6%-10.8%+28.2%+18.0%
FCF MarginFCF ÷ Revenue-16.1%-11.3%-6.5%+26.8%+24.0%
Rev. Growth (YoY)Latest quarter vs prior year+31.7%-21.2%-7.4%+23.0%+1.2%
EPS Growth (YoY)Latest quarter vs prior year+58.3%-5.9%-6.1%+18.8%+76.5%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ARAY leads this category, winning 4 of 6 comparable metrics.

At 26.7x trailing earnings, LNTH trades at a 54% valuation discount to ISRG's 57.6x P/E. On an enterprise value basis, ARAY's 11.0x EV/EBITDA is more attractive than ISRG's 43.6x.

MetricAPYX logoAPYXApyx Medical Corp…SSKN logoSSKNSTRATA Skin Scien…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…LNTH logoLNTHLantheus Holdings…
Market CapShares × price$149M$7M$35M$161.1B$5.9B
Enterprise ValueMkt cap + debt − cash$157M$16M$154M$158.0B$5.6B
Trailing P/EPrice ÷ TTM EPS-13.19x-0.67x-18.91x57.62x26.69x
Forward P/EPrice ÷ next-FY EPS est.43.84x17.52x
PEG RatioP/E ÷ EPS growth rate2.65x
EV / EBITDAEnterprise value multiple10.99x43.62x14.61x
Price / SalesMarket cap ÷ Revenue2.82x0.20x0.08x16.00x3.84x
Price / BookPrice ÷ Book value/share10.12x1.34x0.37x9.17x5.72x
Price / FCFMarket cap ÷ FCF64.67x16.73x
ARAY leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

LNTH leads this category, winning 6 of 9 comparable metrics.

LNTH delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-8 for SSKN. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to SSKN's 3.31x. On the Piotroski fundamental quality scale (0–9), ARAY scores 6/9 vs SSKN's 4/9, reflecting solid financial health.

MetricAPYX logoAPYXApyx Medical Corp…SSKN logoSSKNSTRATA Skin Scien…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…LNTH logoLNTHLantheus Holdings…
ROE (TTM)Return on equity-88.5%-8.4%-77.5%+16.9%+24.3%
ROA (TTM)Return on assets-14.9%-35.9%-10.1%+14.8%+12.4%
ROICReturn on invested capital-22.1%-38.9%+3.0%+15.0%+30.6%
ROCEReturn on capital employed-11.8%-36.0%+2.8%+16.5%+17.1%
Piotroski ScoreFundamental quality 0–944665
Debt / EquityFinancial leverage2.65x3.31x2.17x0.02x0.00x
Net DebtTotal debt minus cash$8M$9M$119M-$3.1B-$358M
Cash & Equiv.Liquid assets$32M$7M$57M$3.4B$359M
Total DebtShort + long-term debt$39M$16M$176M$303M$738,000
Interest CoverageEBIT ÷ Interest expense-0.97x-4.63x-1.86x11.72x
LNTH leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

LNTH leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $109 for SSKN. Over the past 12 months, APYX leads with a +184.8% total return vs SSKN's -93.3%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs SSKN's -74.5% — a key indicator of consistent wealth creation.

MetricAPYX logoAPYXApyx Medical Corp…SSKN logoSSKNSTRATA Skin Scien…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…LNTH logoLNTHLantheus Holdings…
YTD ReturnYear-to-date+1.7%-86.2%-65.5%-19.3%+35.3%
1-Year ReturnPast 12 months+184.8%-93.3%-78.4%-15.4%+13.1%
3-Year ReturnCumulative with dividends+2.3%-98.3%-91.8%+49.6%-4.0%
5-Year ReturnCumulative with dividends-62.9%-98.9%-93.9%+58.7%+314.2%
10-Year ReturnCumulative with dividends-45.0%-99.6%-94.5%+554.2%+4192.5%
CAGR (3Y)Annualised 3-year return+0.8%-74.5%-56.6%+14.4%-1.4%
LNTH leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — SSKN and LNTH each lead in 1 of 2 comparable metrics.

SSKN is the less volatile stock with a -0.24 beta — it tends to amplify market swings less than ARAY's 2.42 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs SSKN's 4.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricAPYX logoAPYXApyx Medical Corp…SSKN logoSSKNSTRATA Skin Scien…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…LNTH logoLNTHLantheus Holdings…
Beta (5Y)Sensitivity to S&P 5001.96x-0.24x2.42x1.02x0.47x
52-Week HighHighest price in past year$4.50$3.86$2.10$603.88$93.00
52-Week LowLowest price in past year$1.08$0.11$0.28$427.84$47.25
% of 52W HighCurrent price vs 52-week peak+79.1%+4.5%+14.0%+75.1%+97.8%
RSI (14)Momentum oscillator 0–10028.641.658.442.461.2
Avg Volume (50D)Average daily shares traded162K14K1.4M1.8M886K
Evenly matched — SSKN and LNTH each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: APYX as "Buy", ISRG as "Buy", LNTH as "Buy". Consensus price targets imply 68.5% upside for APYX (target: $6) vs 11.0% for LNTH (target: $101).

MetricAPYX logoAPYXApyx Medical Corp…SSKN logoSSKNSTRATA Skin Scien…ARAY logoARAYAccuray Incorpora…ISRG logoISRGIntuitive Surgica…LNTH logoLNTHLantheus Holdings…
Analyst RatingConsensus buy/hold/sellBuyBuyBuy
Price TargetConsensus 12-month target$6.00$622.60$101.00
# AnalystsCovering analysts95517
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+1.4%+5.1%
Insufficient data to determine a leader in this category.
Key Takeaway

LNTH leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). ISRG leads in 1 (Income & Cash Flow). 1 tied.

Best OverallLantheus Holdings, Inc. (LNTH)Leads 2 of 6 categories
Loading custom metrics...

APYX vs SSKN vs ARAY vs ISRG vs LNTH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is APYX or SSKN or ARAY or ISRG or LNTH a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 26. 7x trailing P/E (17. 5x forward), making it the more compelling value choice. Analysts rate Apyx Medical Corporation (APYX) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — APYX or SSKN or ARAY or ISRG or LNTH?

On trailing P/E, Lantheus Holdings, Inc.

(LNTH) is the cheapest at 26. 7x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, Lantheus Holdings, Inc. is actually cheaper at 17. 5x.

03

Which is the better long-term investment — APYX or SSKN or ARAY or ISRG or LNTH?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +314. 2%, compared to -98. 9% for STRATA Skin Sciences, Inc. (SSKN). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus SSKN's -99. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — APYX or SSKN or ARAY or ISRG or LNTH?

By beta (market sensitivity over 5 years), STRATA Skin Sciences, Inc.

(SSKN) is the lower-risk stock at -0. 24β versus Accuray Incorporated's 2. 42β — meaning ARAY is approximately -1092% more volatile than SSKN relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 3% for STRATA Skin Sciences, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — APYX or SSKN or ARAY or ISRG or LNTH?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Accuray Incorporated grew EPS 90. 3% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — APYX or SSKN or ARAY or ISRG or LNTH?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus -30. 1% for STRATA Skin Sciences, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus -27. 6% for SSKN. At the gross margin level — before operating expenses — ISRG leads at 66. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is APYX or SSKN or ARAY or ISRG or LNTH more undervalued right now?

On forward earnings alone, Lantheus Holdings, Inc.

(LNTH) trades at 17. 5x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 26. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for APYX: 68. 5% to $6. 00.

08

Which pays a better dividend — APYX or SSKN or ARAY or ISRG or LNTH?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is APYX or SSKN or ARAY or ISRG or LNTH better for a retirement portfolio?

For long-horizon retirement investors, STRATA Skin Sciences, Inc.

(SSKN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 24)). Accuray Incorporated (ARAY) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SSKN: -99. 6%, ARAY: -94. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between APYX and SSKN and ARAY and ISRG and LNTH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: APYX is a small-cap quality compounder stock; SSKN is a small-cap quality compounder stock; ARAY is a small-cap quality compounder stock; ISRG is a mid-cap high-growth stock; LNTH is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

APYX

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 15%
  • Gross Margin > 22%
Run This Screen
Stocks Like

SSKN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 34%
Run This Screen
Stocks Like

ARAY

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 16%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform APYX and SSKN and ARAY and ISRG and LNTH on the metrics below

Revenue Growth>
%
(APYX: 31.7% · SSKN: -21.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.